GAMIDA CELL LTD (GMDA) Fundamental Analysis & Valuation

NASDAQ:GMDA • IL0011552663

Current stock price

0.0327 USD
-0.01 (-18.25%)
At close:
0.032 USD
0 (-2.14%)
After Hours:

This GMDA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. GMDA Profitability Analysis

1.1 Basic Checks

  • In the past year GMDA has reported negative net income.
  • GMDA had a negative operating cash flow in the past year.
  • In the past 5 years GMDA always reported negative net income.
  • In the past 5 years GMDA always reported negative operating cash flow.
GMDA Yearly Net Income VS EBIT VS OCF VS FCFGMDA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 -20M -40M -60M -80M

1.2 Ratios

  • With a Return On Assets value of -61.65%, GMDA is not doing good in the industry: 60.48% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -61.65%
ROE N/A
ROIC N/A
ROA(3y)-61.87%
ROA(5y)-54.88%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GMDA Yearly ROA, ROE, ROICGMDA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 500 1K 1.5K 2K

1.3 Margins

  • GMDA has a Gross Margin of 18.53%. This is in the better half of the industry: GMDA outperforms 75.47% of its industry peers.
  • The Profit Margin and Operating Margin are not available for GMDA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GMDA Yearly Profit, Operating, Gross MarginsGMDA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -1K -2K -3K -4K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. GMDA Health Analysis

2.1 Basic Checks

  • GMDA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, GMDA has more shares outstanding
  • GMDA has a worse debt/assets ratio than last year.
GMDA Yearly Shares OutstandingGMDA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M
GMDA Yearly Total Debt VS Total AssetsGMDA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

  • GMDA has an Altman-Z score of -8.53. This is a bad value and indicates that GMDA is not financially healthy and even has some risk of bankruptcy.
  • GMDA has a Altman-Z score of -8.53. This is in the lower half of the industry: GMDA underperforms 74.45% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -8.53
ROIC/WACCN/A
WACC5.78%
GMDA Yearly LT Debt VS Equity VS FCFGMDA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M 100M

2.3 Liquidity

  • GMDA has a Current Ratio of 2.16. This indicates that GMDA is financially healthy and has no problem in meeting its short term obligations.
  • GMDA has a Current ratio of 2.16. This is in the lower half of the industry: GMDA underperforms 75.98% of its industry peers.
  • GMDA has a Quick Ratio of 2.09. This indicates that GMDA is financially healthy and has no problem in meeting its short term obligations.
  • GMDA's Quick ratio of 2.09 is on the low side compared to the rest of the industry. GMDA is outperformed by 75.47% of its industry peers.
Industry RankSector Rank
Current Ratio 2.16
Quick Ratio 2.09
GMDA Yearly Current Assets VS Current LiabilitesGMDA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. GMDA Growth Analysis

3.1 Past

  • GMDA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 49.19%, which is quite impressive.
EPS 1Y (TTM)49.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.67%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, GMDA will show a very strong growth in Earnings Per Share. The EPS will grow by 50.79% on average per year.
  • The Revenue is expected to grow by 182.44% on average over the next years. This is a very strong growth
EPS Next Y9.37%
EPS Next 2Y50.84%
EPS Next 3Y51.21%
EPS Next 5Y50.79%
Revenue Next Year808.75%
Revenue Next 2Y935.67%
Revenue Next 3Y499.3%
Revenue Next 5Y182.44%

3.3 Evolution

GMDA Yearly Revenue VS EstimatesGMDA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
GMDA Yearly EPS VS EstimatesGMDA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 4 6

More info and screens

Find the best growth stocksShow best growing peers

1

4. GMDA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for GMDA. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GMDA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GMDA Price Earnings VS Forward Price EarningsGMDA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GMDA Per share dataGMDA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6

4.3 Compensation for Growth

  • A more expensive valuation may be justified as GMDA's earnings are expected to grow with 51.21% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y50.84%
EPS Next 3Y51.21%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. GMDA Dividend Analysis

5.1 Amount

  • GMDA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

GMDA Fundamentals: All Metrics, Ratios and Statistics

GAMIDA CELL LTD

NASDAQ:GMDA (4/5/2024, 8:00:00 PM)

After market: 0.032 0 (-2.14%)

0.0327

-0.01 (-18.25%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-27
Earnings (Next)05-07
Inst Owners0.24%
Inst Owner Change0%
Ins Owners3.15%
Ins Owner Change0%
Market Cap4.34M
Revenue(TTM)1.78M
Net Income(TTM)-63.00M
Analysts80
Price Target4.42 (13416.82%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)84.15%
Min EPS beat(2)74.12%
Max EPS beat(2)94.18%
EPS beat(4)3
Avg EPS beat(4)28.83%
Min EPS beat(4)-56.46%
Max EPS beat(4)94.18%
EPS beat(8)5
Avg EPS beat(8)12.83%
EPS beat(12)8
Avg EPS beat(12)12.1%
EPS beat(16)10
Avg EPS beat(16)4.74%
Revenue beat(2)1
Avg Revenue beat(2)-34.95%
Min Revenue beat(2)-72.29%
Max Revenue beat(2)2.4%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)8.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.3%
Revenue NY rev (1m)18.03%
Revenue NY rev (3m)17.94%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.44
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.63
EYN/A
EPS(NY)-0.57
Fwd EYN/A
FCF(TTM)-0.6
FCFYN/A
OCF(TTM)-0.6
OCFYN/A
SpS0.01
BVpS-0.02
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -61.65%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.53%
FCFM N/A
ROA(3y)-61.87%
ROA(5y)-54.88%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 53.41%
Cap/Sales 60.7%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.16
Quick Ratio 2.09
Altman-Z -8.53
F-Score4
WACC5.78%
ROIC/WACCN/A
Cap/Depr(3y)1665.53%
Cap/Depr(5y)1683.47%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)49.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.67%
EPS Next Y9.37%
EPS Next 2Y50.84%
EPS Next 3Y51.21%
EPS Next 5Y50.79%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year808.75%
Revenue Next 2Y935.67%
Revenue Next 3Y499.3%
Revenue Next 5Y182.44%
EBIT growth 1Y3.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-4.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-12.35%
OCF growth 3YN/A
OCF growth 5YN/A

GAMIDA CELL LTD / GMDA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for GAMIDA CELL LTD?

ChartMill assigns a fundamental rating of 2 / 10 to GMDA.


Can you provide the valuation status for GAMIDA CELL LTD?

ChartMill assigns a valuation rating of 1 / 10 to GAMIDA CELL LTD (GMDA). This can be considered as Overvalued.


Can you provide the profitability details for GAMIDA CELL LTD?

GAMIDA CELL LTD (GMDA) has a profitability rating of 1 / 10.


Can you provide the financial health for GMDA stock?

The financial health rating of GAMIDA CELL LTD (GMDA) is 2 / 10.